Alzheimer's disease

News

FDA clears AI-powered digital test for early dementia

The FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out on an iPad in five minutes.

News

Biogen's Aduhelm rollout goes from bad to worse

Analysts were predicting sales of Biogen's recently approved Alzheimer's therapy Aduhelm may start to gather a little momentum in the third quarter, but the drug seems to be going into reve

News

Illustration of the thought processes in the brain

Eisai-backed trial will assess Altoida's digital test for ea...

A software platform developed by Altoida that uses augmented reality and artificial intelligence to diagnose neurological diseases in their earliest stages is being tested in a five-year tr

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

Data dive finds cheap diuretic could be Alzheimer's drug

A data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have potential as a treatment for some patients with Alzheimer's disease.

News

Could Pfizer's Inlyta have a role in Alzheimer's disease?

Pfizer's tyrosine kinase inhibitor Inlyta is already a cornerstone of treatment for some forms of cancer, but could have potential as a therapy for Alzheimer's disease as well, according to

News

Closeup of X-ray photography of human brain

Biogen, Eisai double down on Alzheimer's with lecanemab fili...

Biogen and Eisai's first Alzheimer's disease drug Aduhelm is facing an uphill battle in the US market, but the partners are forging ahead with their second candidate lecanemab, starting a r

FDA clears AI-powered digital test for early dementia

Biogen's Aduhelm rollout goes from bad to worse

Eisai-backed trial will assess Altoida's digital test for ea...

Data dive finds cheap diuretic could be Alzheimer's drug

Could Pfizer's Inlyta have a role in Alzheimer's disease?

Biogen, Eisai double down on Alzheimer's with lecanemab fili...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks